Home › Metabolic Disorders › Illinois
Metabolic Disorders clinical trials in Illinois
7 studies for Metabolic Disorders are looking for participants at sites in Illinois.
Cities in Illinois
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
- Endeavor Health - Family Medicine Administration, Evanston
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chicago
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chicago
- 89bio Clinical Study Site, Glenview
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
- University of Illinois Hospital & Health Sciences System, Chicago
RecruitingPhase 1/2
Ages 35 to 70 · All sexes · Updated Aug 21, 2026 · NCT06575426An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 3
24 Hours – 7 Months · Men · Updated Aug 12, 2026 · NCT06255782Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
RecruitingPhase 1/2
All ages · All sexes · Updated Jan 22, 2026 · NCT04159103Rare and Atypical Diabetes Network
- University of Chicago, Chicago
RecruitingObservational study
All ages · All sexes · Updated Aug 14, 2025 · NCT05544266From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.